Ignore This Picture
Spacer
faculty photo

Robert M. Strauss, MD

Clinical Associate Professor of Medicine
Department: Medicine

Contact information
Penn Presbyterian Medical Center
51 North 39th Street
Philadelphia, PA 19104
Education:
BS
Escuela Secundaria y Preparatoria de la Ciudad, de Mexico, Mexico City, Mexico, 1976.
MD
Universidad Nacional Autonoma de Mexico, Mexico City, Mexico, 1983.
Post-Graduate Training
Intern in Medicine, Emory University, Atlanta, GA, 1983-1984.
Resident in Medicine, Emory University, Atlanta, GA , 1984-1986.
Clinical and Research Gastroenterology Fellowship in Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA, 1986-1990.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Have participated as Principal Investigator or Associate Investigator in numerous national trials regarding viral therapy of Hepatitis C as well as trials related to Inflammatory Bowel Disease.

Participated in a trial of fatty liver and steatohepatitis.

Several trials related to management of fluid overload in patients with portal hypertension.

Selected Publications

Poordad F, McCone J, Bacon BR: Boceprovir for untreated chronic HCV genotype 1 Infection. New England Journal of Medicine 364: 1195-206, 2011.

McHutchinson JG, Lavitz EJ, Shiffman ML: Peg-interferon Alfa-2b or Alfa-2a with Ribavirin for treatment of Hepatitis C Infection. New England Journal of Medicine 361: 580-93, 2009.

Jacobson IM, Brown RS, Freihch B: Peg interferon alfa-2b and weight based or flat dose Ribavirin chronic Hepatitis patients: A randomized trial. Hepatology 46(4): 971-81, 2007.

Tadros, TS, Strauss RM, Cohen C, Gal A : Galanin, immunoreactivity in paragangliomas but not in carcinoid tumors. Applied Immunohistochemistry and Molecular morphology 11(3): 250-252, 2003.

Strauss RM, Dienstag JL: Ascites and Its Complications. Oxford Textbook of Surgery. Second Edition. Morris PJ, Wood WC (eds.). Oxford University Press, Oxford and New York, Page: 1753-1761, 2000.

Vassilopouos D, Camisa D, Strauss RM: Selected drug complications and treatment conflicts in the presence of coexistent diseases. Rheumatic Disease Clin of North America 23(3): 745-777, Aug 1999.

Fukushima T, Waring P, Strauss RM: Hypertrophic gastric folds detected by x-ray in a co-host of Japanese National residing in the USA. Significance of H. Pylori infection and gender. American Journal of Gastroenterology 94(9): 2607, 1999.

Farrell GC, Bacon BR, Golden RD, and the Clinical Advisory Group of Hepatitis C Comparative Study: Lymphoblastoid interferon improves the long term response to a six-month course of treatments in Chronic Hepatitis C Compared with recombinant interfero-a2b. Results of an international randomized controlled trial. Hepatology 27(4): 1121-27, April 1998.

Tandon K, Goodrich MA, Wenger J, DeLong MS, Strauss RM: Dietary intake of fat does not influence colonic levels of glutathione-S transferase (GST) and NAD (P) H: quinine-reductase (QR). Gastroenterology 1998 114: G2838, 1998.

*Chalasani N, Martin LG, Strauss RM, Boyer TD: Transjugular interhepatic port systemic shunt (TIPS) for refractory hepatic hydrothorax (HHT) – good for the lungs, not so good for the liver. Hepatology 1997 26: 630A, 1997.

back to top
Last updated: 03/31/2017
The Trustees of the University of Pennsylvania
 
Spacer

[Return to faculty list]

Spacer
University of Pennsylvania | School of Medicine